Read + Share
Amedeo Smart
Independent Medical Education
Neelapu SS, Chavez JC, Sehgal AR, Epperla N, et al. Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma. J Clin Oncol 2025 Oct 16:JCO2500668. doi: 10.1200/JCO-25-00668.PMID: 41100801
Email
LinkedIn
Privacy Policy